Gedeon Richter, the Hungarian medicine manufacturer has acquired Chinese Rxmidas Pharmaceuticals Holding’s 50 percent stake in Gedeon Richter Rxmidas Joint Venture Co. Ltd. Through the transaction, the company now has a 100 percent share and is the sole owner of joint venture. In December 2010 Richter set up the firm, contributing 50 percent of the equity. It’s important step for the company which is planning to develop on the Chinese market.
